
Teleflex Raises 2025 Outlook Following Strong Q2 and BIOTRONIK Acquisition
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported second quarter results that exceeded expectations and raised its full-year 2025 guidance following the successful acquisition of BIOTRONIK’s Vascular Intervention business.
Teleflex Raises 2025 Outlook Following Strong Q2 and BIOTRONIK Acquisition Read More